TY - JOUR T1 - TRAIN in response to treatment with anti-cancer small molecule destabilizing chromatin JF - bioRxiv DO - 10.1101/142471 SP - 142471 AU - Katerina Leonova AU - Alfiya Safina AU - Elimelech Nesher AU - Poorva Sandlesh AU - Rachel Pratt AU - Catherine Burkhart AU - Britney Lipchick AU - Costakis Frangou AU - Igor Koman AU - Jianmin Wang AU - Kirill Kirsanov AU - Marianna G. Yakubovskaya AU - Andrei V. Gudkov AU - Katerina Gurova Y1 - 2017/01/01 UR - http://biorxiv.org/content/early/2017/05/25/142471.abstract N2 - Genome stability is in the focus of research for many decades, while stability and integrity of chromatin is far less studied. Cell identity in multicellular organism is completely dependent on chromatin stability, therefore there should be mechanisms ensuring maintenance of epigenetic integrity. Previously, we have found that loss of DNA methylation in the absence of p53 leads to the transcription of silenced repetitive elements, such as pericentromeric repeats and endogenous viruses, what causes activation of IFN response, similarly to viral invasion, and IFN-dependent cell death. We named this phenomenon TRAIN (Transcription of Repeats Activates INterferon). Now we found that small molecule, curaxin, which destabilizes nucleosome via binding to DNA and deforming helix shape, causes TRAIN independently on p53 status. Curaxin demonstrated activity as cancer treatment and preventive agent via established previously p53 activating and NF-kappaB inhibiting activities. Here we showed that activation of IFN response is an additional mechanism of inhibition of oncogene-induced transformation by curaxin. Our data suggest that TRAIN is a response to the loss of chromatin stability and one of the mechanisms which prevents oncogene-induced transformation. ER -